These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 16531925

  • 1. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N, Kulak H, Tokmak E, Tar P, Ibiş E, Aras G.
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.
    Cancer; 2003 Mar 01; 97(5):1186-94. PubMed ID: 12599224
    [Abstract] [Full Text] [Related]

  • 3. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO, Tari P, Tokmak E, Aras G.
    Clin Nucl Med; 2007 Apr 01; 32(4):279-81. PubMed ID: 17413573
    [Abstract] [Full Text] [Related]

  • 4. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M, Bin Yousef H, Greer W, Faraz H, Al Sobhi S, Al Zahrani A, Raef H, Al Ghamdi A, Al Kadhi Y, Al Dayel F.
    ANZ J Surg; 2008 Mar 01; 78(3):139-43. PubMed ID: 18269475
    [Abstract] [Full Text] [Related]

  • 5. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
    Sanz J, Cerpa F, Domínguez M, Franco C, Jadresic A, Pérez G, Phillipi V.
    Rev Med Chil; 1999 Jul 01; 127(7):821-6. PubMed ID: 10668290
    [Abstract] [Full Text] [Related]

  • 6. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
    Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L.
    J Nucl Med; 1997 May 01; 38(5):669-75. PubMed ID: 9170425
    [Abstract] [Full Text] [Related]

  • 7. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M, Behar R, Wu TC, Straus F, McCormick M, DeGroot LJ, Kaplan EL.
    Surgery; 1986 Dec 01; 100(6):1108-15. PubMed ID: 3787466
    [Abstract] [Full Text] [Related]

  • 8. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C, Jarosz H, Lawrence AM, Paloyan E.
    Surg Gynecol Obstet; 1989 Nov 01; 169(5):429-34. PubMed ID: 2814754
    [Abstract] [Full Text] [Related]

  • 9. Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer.
    Leblanc G, Tabah R, Liberman M, Sampalis J, Younan R, How J.
    Surgery; 2004 Dec 01; 136(6):1275-80. PubMed ID: 15657587
    [Abstract] [Full Text] [Related]

  • 10. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H.
    Cancer; 1996 Jan 01; 77(1):172-80. PubMed ID: 8630926
    [Abstract] [Full Text] [Related]

  • 11. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR, Sandoval BA.
    Surg Oncol Clin N Am; 1998 Oct 01; 7(4):893-910. PubMed ID: 9735140
    [Abstract] [Full Text] [Related]

  • 12. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP, Black T, Holcomb GW, Sklar C, Azizkhan RG, Haase GM, Newman KD.
    J Pediatr Surg; 2000 Jun 01; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [Abstract] [Full Text] [Related]

  • 13. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E, Heitz P, Martina B.
    Schweiz Med Wochenschr; 1995 Nov 18; 125(46):2226-36. PubMed ID: 8525342
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P, Igerc I, Kohlfürst S.
    Wien Med Wochenschr; 2005 Oct 18; 155(19-20):429-35. PubMed ID: 16424998
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H, Birrer A, Lüscher D, Kinser J.
    Schweiz Med Wochenschr; 1992 Nov 28; 122(48):1843-57. PubMed ID: 1462145
    [Abstract] [Full Text] [Related]

  • 18. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM, Eski S, Freeman JL.
    Arch Otolaryngol Head Neck Surg; 2009 Apr 28; 135(4):355-9. PubMed ID: 19380356
    [Abstract] [Full Text] [Related]

  • 19. Hurthle cell tumor.
    Chen HY, Benjamin LB, Chen MF.
    Int Surg; 1996 Apr 28; 81(2):168-70. PubMed ID: 8912085
    [Abstract] [Full Text] [Related]

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B, Handkiewicz-Junak D, Wloch J.
    Endocr Relat Cancer; 2005 Dec 28; 12(4):773-803. PubMed ID: 16322322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.